Kearns Evan 4
4 · Cogent Biosciences, Inc. · Filed Dec 30, 2025
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-12-26$38.70/sh−65,000$2,515,500→ 109,398 total
Footnotes (2)
- [F1]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.52 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.